Controversial New Alzheimer’s Treatments Gain Ground despite Serious Side Effects

This article is part of “Innovations In: Alzheimer’s Disease” an editorially independent special report that was produced with financial support from Eisai. One of neurologist Anelyssa D’Abreu’s least favorite tasks is giving her patients a dreaded diagnosis: early-stage Alzheimer’s disease. But it’s not quite as bad as it used to be. Today when they ask,…

Read More
Back To Top